dronedarone has been researched along with Disease Models, Animal in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (7.41) | 18.2507 |
2000's | 2 (7.41) | 29.6817 |
2010's | 20 (74.07) | 24.3611 |
2020's | 3 (11.11) | 2.80 |
Authors | Studies |
---|---|
Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
Chan, ECY; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Kambayashi, R; Matsumoto, A; Nunoi, Y; Sugiyama, A; Takei, Y; Venkatesan, G | 1 |
Apicella, C; Fabritz, L; Fobian, D; Gupta, S; Holmes, AP; Kabir, SN; Kirchhof, P; Kuhlmann, SM; O'Reilly, M; O'Shea, C; Pavlovic, D; Reyat, JS; Saxena, P; Smith, GL; Syeda, F; Workman, AJ | 1 |
Hamlin, RL; Kijtawornrat, A; Limprasutr, V; Saengklub, N; Sawangkoon, S | 1 |
Ando, K; Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Lubna, NJ; Motokawa, Y; Naito, AT; Nakamura, Y; Sugiyama, A; Yamazaki, H | 1 |
Bukowska, A; Chilukoti, RK; Darm, K; Goette, A; Homuth, G; Lendeckel, J; Lendeckel, U; Peters, B; Scharf, C; Sühling, M; Utpatel, K; Völker, U; Wolke, C | 1 |
Chmielewski, J; Daniluk, J; Florek-Łuszczki, M; Karwan, S; Sawicka, KM; Wawryniuk, A; Łuszczki, JJ | 1 |
Chmielewski, J; Daniluk, J; Florek-Łuszczki, M; Karwan, S; Sawicka, KM; Wawryniuk, A; Wróblewska-Łuczka, P; Łuszczki, JJ | 1 |
Aves, T; Dorian, P; Fujii, H; Glover, BM; Hu, X; Leong-Poi, H; Ramadeen, A; Zou, L | 1 |
Breithardt, G; Eckardt, L; Frommeyer, G; Kaese, S; Kaiser, D; Milberg, P; Uphaus, T | 1 |
Belardinelli, L; Kanas, AF; Machado, AD; Nearing, BD; Pagotto, VP; Sobrado, LF; Sobrado, MF; Varone, BB; Verrier, RL; Zeng, D | 1 |
Bouitbir, J; Donzelli, M; Felser, A; Krähenbühl, S; Morand, R; Schnell, D; Stoller, A; Terracciano, L | 1 |
Bukowska, A; Evert, M; Goette, A; Kühn, JP; Lendeckel, U; Linke, J; Peters, B; Utpatel, K; Wolke, C | 1 |
Chen, KH; Du, XL; Jin, MW; Li, GR; Liu, H; Sun, HY; Wang, Y; Xiao, GS; Xu, XH; Yang, L | 1 |
Dechering, DG; Eckardt, L; Ellermann, C; Frommeyer, G; Kochhäuser, S; Leitz, P; Puckhaber, D; Reinke, F | 1 |
Goette, A; Hohnloser, S; Kirch, W; Lewalter, T; Pittrow, D | 1 |
Antzelevitch, C; Belardinelli, L; Burashnikov, A | 1 |
Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Sicouri, S | 1 |
Cingolani, E; Singh, BN | 1 |
Lip, GY; Pamukcu, B | 1 |
Doerfler, A; Engelhorn, T; Heusch, G; Schulz, R; Schwarz, MA | 1 |
Bui-Xuan, B; Chevalier, P; Morel, E; Timour, Q | 1 |
Belardinelli, L; Kanas, AF; Nearing, BD; Pagotto, VP; Sobrado, MF; Verrier, RL; Zeng, D | 1 |
Agelaki, MG; Baltogiannis, GG; Fotopoulos, A; Kolettis, TM; Korantzopoulos, P; Pantos, C; Tsalikakis, DG | 1 |
Chatelain, P; Finance, O; Manning, A | 1 |
Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J | 1 |
de Groot, SH; Leunissen, JD; Molenschot, MM; Schoenmakers, M; van Der Hulst, FF; van Opstal, JM; Verduyn, SC; Vos, MA; Wellens, HJ | 1 |
3 review(s) available for dronedarone and Disease Models, Animal
Article | Year |
---|---|
[Clinical pharmacology and electrophysiological properties of dronedarone].
Topics: Adrenergic Antagonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Calcium Channels; Disease Models, Animal; Dronedarone; Electrocardiography; Half-Life; Humans; Metabolic Clearance Rate; Sodium Channels | 2010 |
A new agent for atrial fibrillation: electrophysiological properties of dronedarone.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Electrophysiologic Techniques, Cardiac; Humans | 2010 |
Dronedarone as a new treatment option for atrial fibrillation patients: pharmacokinetics, pharmacodynamics and clinical practice.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Clinical Trials as Topic; Disease Models, Animal; Dronedarone; Female; Heart Rate; Humans; Male | 2011 |
24 other study(ies) available for dronedarone and Disease Models, Animal
Article | Year |
---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
An exploratory analysis of effects of poyendarone, a deuterated analogue of dronedarone, on the canine model of paroxysmal atrial fibrillation.
Topics: Administration, Intravenous; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Blood Pressure; Deuterium; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Female; Heart Rate | 2021 |
Atrial resting membrane potential confers sodium current sensitivity to propafenone, flecainide and dronedarone.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Female; Flecainide; Heart Atria; Male; Membrane Potentials; Mice; Propafenone; Sodium; Voltage-Gated Sodium Channel Blockers | 2021 |
Dronedarone attenuates the duration of atrial fibrillation in a dog model of sustained atrial fibrillation.
Topics: Action Potentials; Administration, Oral; Amiodarone; Animals; Atrial Fibrillation; Disease Models, Animal; Dogs; Dronedarone; Heart Atria; Humans; Refractory Period, Electrophysiological; Time Factors | 2017 |
In vivo Analysis of the Anti-atrial Fibrillatory, Proarrhythmic and Cardiodepressive Profiles of Dronedarone as a Guide for Safety Pharmacological Evaluation of Antiarrhythmic Drugs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Output; Disease Models, Animal; Dogs; Dronedarone; Electrocardiography; Heart Conduction System; Heart Rate; Male; Refractory Period, Electrophysiological; Risk Assessment; Time Factors; Torsades de Pointes; Ventricular Function, Left; Ventricular Pressure | 2018 |
Integration of "omics" techniques: Dronedarone affects cardiac remodeling in the infarction border zone.
Topics: Animals; Cardiovascular Agents; Disease Models, Animal; Dronedarone; Gene Expression Profiling; Immunoblotting; Microarray Analysis; Myocardial Infarction; Proteome; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; Swine; Treatment Outcome; Two-Dimensional Difference Gel Electrophoresis; Ventricular Remodeling | 2018 |
Influence of dronedarone (a class III antiarrhythmic drug) on the anticonvulsant potency of four classical antiepileptic drugs in the tonic-clonic seizure model in mice.
Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Behavior, Animal; Brain; Carbamazepine; Disease Models, Animal; Dronedarone; Drug Interactions; Male; Phenobarbital; Phenytoin; Seizures; Valproic Acid | 2019 |
Dronedarone (a multichannel blocker) enhances the anticonvulsant potency of lamotrigine, but not that of lacosamide, pregabalin and topiramate in the tonic-clonic seizure model in mice.
Topics: Animals; Anti-Arrhythmia Agents; Anticonvulsants; Disease Models, Animal; Dronedarone; Drug Synergism; Drug Therapy, Combination; Lacosamide; Lamotrigine; Male; Mice; Pregabalin; Seizures; Topiramate | 2019 |
Dronedarone and Captisol-enabled amiodarone in an experimental cardiac arrest.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiopulmonary Resuscitation; Disease Models, Animal; Dronedarone; Electric Countershock; Heart Arrest; Heart Rate; Swine; Ventricular Fibrillation | 2013 |
Antiarrhythmic effect of ranolazine in combination with class III drugs in an experimental whole-heart model of atrial fibrillation.
Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Female; Piperazines; Rabbits; Ranolazine; Refractory Period, Electrophysiological; Sotalol | 2013 |
Inhibition of I(f) in the atrioventricular node as a mechanism for dronedarone's reduction in ventricular rate during atrial fibrillation.
Topics: Amiodarone; Animals; Atrial Fibrillation; Atrioventricular Node; Benzazepines; Cyclic Nucleotide-Gated Cation Channels; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Heart Rate; Heart Ventricles; Ivabradine; Male; Swine; Ventricular Function, Left | 2013 |
Hepatic toxicity of dronedarone in mice: role of mitochondrial β-oxidation.
Topics: Alanine Transaminase; Amiodarone; Animals; Anti-Arrhythmia Agents; bcl-2-Associated X Protein; Disease Models, Animal; Dronedarone; Fatty Acids; Fatty Liver; Liver; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria, Liver; Oxidation-Reduction; Oxygen Consumption; Palmitic Acid; Palmitoylcarnitine; Proto-Oncogene Proteins c-bcl-2; RNA, Messenger | 2014 |
Dronedarone does not affect infarct volume as assessed by magnetic resonance imaging in a porcine model of myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Biomarkers; Coronary Vessels; Disease Models, Animal; Dronedarone; Electrocardiography; Hemodynamics; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Myocardial Infarction; Swine; Ventricular Function, Left | 2015 |
Distinctive property and pharmacology of voltage-gated sodium current in rat atrial vs ventricular myocytes.
Topics: Amiodarone; Animals; Cells, Cultured; Disease Models, Animal; Dronedarone; Heart Atria; Heart Ventricles; Myocytes, Cardiac; Patch-Clamp Techniques; Rats; Sodium Channel Blockers; Voltage-Gated Sodium Channels | 2016 |
Interactions of digitalis and class-III antiarrhythmic drugs: Amiodarone versus dronedarone.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Digitalis Glycosides; Disease Models, Animal; Dronedarone; Drug Interactions; Electrocardiography; Heart Conduction System; Rabbits; Ventricular Fibrillation | 2017 |
Acute dronedarone is inferior to amiodarone in terminating and preventing atrial fibrillation in canine atria.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Dronedarone; Electrophysiologic Techniques, Cardiac; Heart Atria; Heart Conduction System; Treatment Outcome | 2010 |
Synergistic effect of the combination of ranolazine and dronedarone to suppress atrial fibrillation.
Topics: Acetanilides; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Dronedarone; Drug Synergism; Drug Therapy, Combination; Piperazines; Ranolazine | 2010 |
Reduction of cerebral infarct size by dronedarone.
Topics: Amiodarone; Animals; Blood Pressure; Body Weight; Disease Models, Animal; Dronedarone; Heart Rate; Infarction, Middle Cerebral Artery; Laser-Doppler Flowmetry; Magnetic Resonance Imaging; Male; Neuroprotective Agents; Rats; Rats, Wistar; Treatment Outcome | 2011 |
Chronic oral amiodarone but not dronedarone therapy increases ventricular defibrillation threshold during acute myocardial ischemia in a closed-chest animal model.
Topics: Acute Disease; Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Occlusion; Defibrillators, Implantable; Disease Models, Animal; Dronedarone; Female; Male; Myocardial Ischemia; Swine; Ventricular Fibrillation | 2012 |
Low doses of ranolazine and dronedarone in combination exert potent protection against atrial fibrillation and vulnerability to ventricular arrhythmias during acute myocardial ischemia.
Topics: Acetanilides; Amiodarone; Animals; Atrial Fibrillation; Chromatography, High Pressure Liquid; Disease Models, Animal; Dronedarone; Drug Therapy, Combination; Electrocardiography; Hemodynamics; Piperazines; Ranolazine; Swine; Tachycardia, Ventricular | 2013 |
Comparative antiarrhythmic efficacy of amiodarone and dronedarone during acute myocardial infarction in rats.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Disease Models, Animal; Dronedarone; Electrocardiography, Ambulatory; Epinephrine; Female; Myocardial Infarction; Norepinephrine; Radioimmunoassay; Random Allocation; Rats; Rats, Wistar; Tachycardia, Ventricular; Telemetry; Thyroid Hormones; Ventricular Fibrillation | 2007 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Death, Sudden, Cardiac; Disease Models, Animal; Dronedarone; Female; Lidocaine; Male; Myocardial Ischemia; Sotalol; Stereoisomerism; Swine; Tachycardia, Ventricular; Ventricular Fibrillation | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Chi-Square Distribution; Disease Models, Animal; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Heart Block; Heart Rate; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Random Allocation; Rats; Sotalol; Ventricular Fibrillation | 1995 |
Chronic amiodarone evokes no torsade de pointes arrhythmias despite QT lengthening in an animal model of acquired long-QT syndrome.
Topics: Action Potentials; Administration, Oral; Amiodarone; Anesthesia; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Catheterization; Disease Models, Animal; Dogs; Dronedarone; Electrocardiography; Electrophysiologic Techniques, Cardiac; Epinephrine; Female; Heart Block; Hemodynamics; Long QT Syndrome; Male; Myocardium; Organ Size; Torsades de Pointes; Vasoconstrictor Agents; Wakefulness | 2001 |